ABSTRACT
In patients with HIV infection, highly active antiretroviral therapy is improving survival, but at the price of a variety of metabolic side effects. Patterns of morbidity and mortality are changing: the leading cause of death is now kidney or liver failure instead of opportunistic infections.
Footnotes
↵* The author has indicated that he has a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest; le, he serves as a consultant for the Immunex, Amgen, SmithKline, Searle, and Schering-Plough corporations.
- Copyright © 2001 The Cleveland Clinic Foundation. All Rights Reserved.